Pulmonary embolism: what happens to the source of the embolus?
D015110:4-Hydroxycoumarins; D000328:Adult; D000368:Aged; D000925:Anticoagulants; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007192:Indenes; D008297:Male; D008875:Middle Aged; D010690:Phlebography; D011379:Prognosis; D011655:Pulmonary Embolism / Q000188:drug therapy* / Q000209:etiology; D012008:Recurrence; D013927:Thrombosis / Q000150:complications / Q000188:drug therapy*; D014812:Vitamin K / Q000037:antagonists & inhibitors / Q000627:therapeutic use
D015110:4-Hydroxycoumarins; D000925:Anticoagulants; D005343:Fibrinolytic Agents; D007192:Indenes; C011664:antivitamins K; D014812:Vitamin K; D006493:Heparin